What Role Does DNA Analysis Play in Modern Disease Diagnostics? ++++

What role does DNA analysis play in modern disease diagnostics? https://www.azolifesciences.com/whitepaper/20260112/What-role-does-DNA-analysis-play-in-modern-disease-diagnostics.aspx?utm_source=news_medical_newsletter&utm_medium=email&utm_campaign=rare_diseases_newsletter_27_january_2026 What role does DNA analysis play in modern disease diagnostics?DNA analysis is a crucial tool for identifying harmful pathogens, such as bacteria, viruses, or fungi, that cause infections. Unraveling liver injury mechanisms in familial hypobetalipoproteinemia https://www.news-medical.net/news/20260124/Unraveling-liver-injury-mechanisms-in-familial-hypobetalipoproteinemia.aspx?utm_source=news_medical_newsletter&utm_medium=email&utm_campaign=rare_diseases_newsletter_27_january_2026 Unraveling liver injury mechanisms in familial hypobetalipoproteinemiaFamilial Hypobetalipoproteinemia (FHBL), caused by variants in the apolipoprotein B (APOB) gene, is a rare autosomal co-dominant monogenic disorder characterized by lifelong low plasma levels of total cholesterol, low-density lipoprotein cholesterol (LDL-C), and APOB. DLL3 on circulating tumor cells predicts tarlatamab success in lung cancer https://www.news-medical.net/news/20260114/DLL3-on-circulating-tumor-cells-predicts-tarlatamab-success-in-lung-cancer.aspx?utm_source=news_medical_newsletter&utm_medium=email&utm_campaign=rare_diseases_newsletter_27_january_2026 A team led by investigators at the Mass General Brigham Cancer Institute has discovered that a particular marker on tumor cells circulating in the blood indicates whether a patient with lung cancer will experience a lasting response to a newly approved immunotherapy called tarlatamab. UT Southwestern performs first regional whole-liver chemotherapy for rare eye cancer https://www.news-medical.net/news/20260121/UT-Southwestern-performs-first-regional-whole-liver-chemotherapy-for-rare-eye-cancer.aspx?utm_source=news_medical_newsletter&utm_medium=email&utm_campaign=rare_diseases_newsletter_27_january_2026 A team at UT Southwestern Medical Center this week became the first in Texas and neighboring states to successfully perform a novel procedure to deliver whole-liver chemotherapy to treat metastatic uveal melanoma, a rare and deadly eye cancer.